Page 92 - SAHCS HIVMed Journal Vol 20 No 1 2019

Page 5 of 6 Case Report

Conclusion Data availability statement

The patient described in this case report is illustrative of Data sharing is not applicable to this article as no new data
the difficulties encountered in accurately diagnosing and were created or analysed in this study.
managing disease caused by non-tuberculous mycobacteria,
in this case M. genavense. Clinicians and laboratory Disclaimer
professionals need to be aware of non-tuberculous
mycobacterial infections, particularly encountered in The views expressed in the article are those of the authors
immunocompromised patients and use available molecular and not an official position of the institution or funder.
diagnostic tools to obtain a diagnosis.
References
Teaching points 1. Böttger EC. Mycobacterium genavense: An emerging pathogen. Eur J Clin
Microbiol Infect Dis. 1994;13(11):932–936. https://doi.org/10.1007/BF02111494
• Mycobacterium genavense should be considered in HIV- 2. Coyle MB, Carlson LC, Wallis CK, et al. Laboratory aspects of ‘Mycobacterium
infected patients with suspected disseminated M. avium genavense’, a proposed species isolated from AIDS patients. J Clin Microbiol.
complex, but whose routine cultures are negative. 1992;30(12):3206–3212.
• This organism is the most common cause of psittacine 3. Dogget JS, Strasfeld L. Disseminated Mycobacterium genavense with pulmonary
nodules in a kidney transplant recipient: Case report and review of the literature
mycobacteriosis. (case report). Transpl Infect Dis. 2011;13:38–43. https://doi.org/10.1111/
j.1399-3062.2010.00545.x
• The clinical presentation of patients with M. genavense 4. Borde JP, Offensperger W-B, Kern WV, et al. Mycobacterium genavense specific
usually includes dissemination involving abdominal mesenteritic syndrome in HIV-infected patients: A new entity of retractile
mesenteritis? (research letter). AIDS. 2013;27:2817–2824. https://doi.
organs. org/10.1097/01.aids.0000433820.25415.17
• Available molecular diagnostic tools are used to obtain a 5. Tribuna C, Ângela C, Eira I, et al. Pulmonary Kaposi sarcoma and disseminated
Mycobacterium genavense infection in an HIV-infected patient (case report).
diagnosis. BMJ Case Rep. 2015;2015:pii: bcr2015211683. https://doi.org/10.1136/bcr-
• A three- or four-drug regimen is typically suggested for 2015-211683
treatment. 6. Wassilew N, Ciaffi L, Calmy A. Mesenterial involvement of Mycobacterium
genavense infection: Hard to find, hard to treat (case report). BMJ Case Rep.
• Treatment is prolonged to more than 12–27 months. 2015;2015:pii:bcr2014208241. https://doi.org/10.1136/bcr-2014-208241
7. Hillebrand-Haverkort ME, Kolk AHJ, Kox LFF, et al. Generalized Mycobacterium
genavense infection in HIV-infected patients: Detection of the mycobacterium in
Acknowledgements hospital tap water. Scan J Infect Dis. 1999;31:63–68. https://doi.org/10.1080/
00365549950161907
The authors wish to thank Prof. Mark Cotton and Prof. 8. Griffith DE, Aksamit T, Brown-Elliott BA, et al. American Thoracic Society
documents. An official ATS/IDSA statement: Diagnosis, treatment, and prevention
Helena Rabie from the University of Stellenbosch and of non-tuberculous mycobacterial diseases. Am J Respir Crit Care Med.
2007;175:367–416. https://doi.org/10.1164/rccm.200604-571ST
Dr Carlos Perez-Velez from the University of Arizona for 9. Santos M, Gil-Brusola A, Escandell A, et al. Mycobacterium genavense infections
their contributions to the management of this case. in a tertiary hospital and reviewed cases in non-HIV patients (clinical study).
Patholog Res Int. 2014;2014:371370. https://doi.org/10.1155/2014/371370
10. Ombelet S, Van Wijngaerden E, Lagrou K, et al. Mycobacterium genavense
Competing interests infection in a solid organ recipient: A diagnostic and therapeutic challenge (case
report). Transpl Infect Dis. 2016;18:125–131. https://doi.org/10.1111/tid.12493
The authors have no conflict of interests. 11. Realini L, De Ridder K, Hirschel B, et al. Blood and charcoal added to acidified agar
media promote the growth of Mycobacterium genavense. Diagn Microbiol Infect
Dis. 1999;34:45–50. https://doi.org/10.1016/S0732-8893(99)00014-0
Authors’ contributions 12. Thomsen VØ, Dragsted UB, Bauer J, et al. Disseminated infection with
Mycobacterium genavense: A challenge to physicians and mycobacteriologists.
J Clin Microbiol. 1999;37(12):3901–3905.
R.D.G. and C.K. contributed to the clinical information. E.H. 13. Cobos-Carrascosa E, Martin-Nalda A, Alvarez M, et al. Protein-losing enteropathy
was the initial pathologist involved in assisting with work- in an HIV-infected pediatric patient with previous disseminated Mycobacterium
genavense infection (correspondence). AIDS. 2015;29:745–753. https://doi.org/
up of the case. P.E. assisted with the trouble shooting of the 10.1097/QAD.0000000000000568
diagnostic work-up. C.C. managed to get the primers for the 14. Abe K, Yamamoto T, Ishii T, et al. Duodenal Mycobacterium genavense infection
mycobacterial 16s rRNA polymerase chain reaction (PCR) in a patient with acquired immunodeficiency syndrome. Endoscopy. 2013;45:
E27–E28. https://doi.org/10.1055/s-0032-1326105
and assisted with the running of that PCR. T.S. assisted with 15. Numbi N, Demeure F, Van Bleyenbergh P, et al. Disseminated Mycobacterium
the histological work-up of the case. T.M. assisted greatly genavense infection in a patient with immunosuppressive therapy and
lymphoproliferative malignancy (case report). Acta Clin Belg. 2014;69(2):
with integrating the HIV management with that of the 142–145. https://doi.org/10.1179/0001551213Z.00000000016
Mycobacterium genavense. E.H. assisted with checking all 16. Krebs T, Zimmerli S, Bodmer T, et al. Mycobacterium genavense infection in
a patient with long-standing chronic lymphocytic leukaemia. J Intern Med.
the lab data in the article. P.E. did the literature review. J.v.I. 2000;248:343–348. https://doi.org/10.1046/j.1365-2796.2000.00730.x
assisted with checking the academic content of the document 17. Martínez Escapa V, Pons Beltrán V, Argüello Viudez L, et al. Intestinal involvement
by Mycobacterium genavense in an immunodepressed patient (brief report).
as an international expert in non-tuberculous mycobacteria. Gastrointest Endosc. 2010;72(5):1108–1110. https://doi.org/10.1016/j.gie.2010.
02.015
T.M. and C.C. assisted with the editing of the final version. 18. Lhuillier E, Brugière O, Veziris N, et al. Relapsing Mycobacterium genavense
All the authors reviewed the document and were satisfied infection as a cause of late death in a lung transplant recipient: Case report and
review of the literature (case report). Exp Clin Transplant. 2012;6:618–620.
with the final version. https://doi.org/10.6002/ect.2012.0052
19. Lu KJ, Grigg A, Leslie D, et al. Mycobacterium genavense duodenitis following
allogeneic peripheral blood stem cell transplantation. Transpl Infect Dis. 2009;
Funding information 11:534–536. https://doi.org/10.1111/j.1399-3062.2009.00431.x
20. Hoefsloot W, Van Ingen J, Peters EJG, et al. Mycobacterium genavense in the
This research received no specific grant from any funding Netherlands: An opportunistic pathogen in HIV and non-HIV immunocompromised
patients. An observational study in 14 cases. Clin Microbiol Infect. 2013;19:
agency in the public, commercial or not-for-profit sectors. 432–437. https://doi.org/10.1111/j.1469-0691.2012.03817.x
http://www.sajhivmed.org.za 85 Open Access